Event Programme

19 November - 21 November

Day 1

Pharmtech & Ingredients Official Opening Ceremony

19 November

10:30 - 11:00

Presentation Zone A, Hall 7, Pavillion 2


Add to calendar 11/19/2019 10:30 11/19/2019 11:00 Official Opening Ceremony Presentation Zone A, Hall 7, Pavillion 2 Europe/Moscow

Ceremony

Official Opening Ceremony

Round table discussion: Total readiness for medicine labelling

Place: Presentation Zone A, Hall 7, Pavillion 2
Participation: free, electronic ticket based
Language: Russian

Co-organised with: Association of Russian Pharmaceutical Manufacturers (ARFP)

19 November

12:00 - 14:00

Presentation Zone A, Hall 7, Pavillion 2


Add to calendar 11/19/2019 12:00 11/19/2019 14:00 Total readiness for medicine labelling The event is dedicated to the implementation of the key national project of monitoring the movement of medicines and launching universal medicine labelling from 1 January 2020.
 
The session will cover issues related to the readiness of all parties involved in distributing medicines, the efficiency of the information system for monitoring the movement of medicines, as well as the initial results of labelling and traceability of medicines included in Russia’s Seven Nosologies Programme.
 
Presentation Zone A, Hall 7, Pavillion 2 Europe/Moscow

Round table

Total readiness for medicine labelling

The event is dedicated to the implementation of the key national project of monitoring the movement of medicines and launching universal medicine labelling from 1 January 2020.
 
The session will cover issues related to the readiness of all parties involved in distributing medicines, the efficiency of the information system for monitoring the movement of medicines, as well as the initial results of labelling and traceability of medicines included in Russia’s Seven Nosologies Programme.
 

Round table discussion: Export potential: new growth points

Place: Presentation Zone A, Hall 7, Pavillion 2
Participation: free, electronic ticket based
Language: Russian

Co-organised with: GMP News

19 November

15:00 - 17:00

Presentation Zone A, Hall 7, Pavillion 2


Add to calendar 11/19/2019 15:00 11/19/2019 17:00 Export potential: new growth points Russian pharmaceutical manufacturers are steadily increasing their volumes of exported products. The growth is not rapid, but in general, the positive trend has been maintained for several years. According to the Federal Customs Service of Russia for the period January-May 2019, the volume of medicines exported from Russia amounted to $287.08 million USD (up 6.27% in comparison with the same period in 2018). The majority of medicines exported go to Ukraine, Kazakhstan and Belarus. According to the forecast of the Russian Federation Ministry for Industry and Trade, by 2030, the volume of medicine exports may increase 5 times. This has become one of the missions of the Pharma 2030 strategy, now under development, and the basis of the International Cooperation and Export national project. In this regard, medicine exports are becoming more and more relevant.
However, manufacturers find themselves in a difficult situation. While Russian medicines are in high demand in CIS countries, access to the highly competitive European market is possible only with government support and initiatives.
The round table discussion Export potential: new growth points, organised in partnership with GMP news magazine, will cover the following issues:
 - Opportunities to increase the export of pharmaceutical products
 - The most effective government support measures for manufacturers engaged in or planning to export
 - Priority areas of integrating into the global pharmaceutical market and do Russian companies have the opportunity to occupy their niche?
Representatives of regulators, leading industry experts, and pharmaceutical companies exporting medicines will discuss case studies and will try to address the most pressing questions.
Presentation Zone A, Hall 7, Pavillion 2 Europe/Moscow

Round table

Export potential: new growth points

Russian pharmaceutical manufacturers are steadily increasing their volumes of exported products. The growth is not rapid, but in general, the positive trend has been maintained for several years. According to the Federal Customs Service of Russia for the period January-May 2019, the volume of medicines exported from Russia amounted to $287.08 million USD (up 6.27% in comparison with the same period in 2018). The majority of medicines exported go to Ukraine, Kazakhstan and Belarus. According to the forecast of the Russian Federation Ministry for Industry and Trade, by 2030, the volume of medicine exports may increase 5 times. This has become one of the missions of the Pharma 2030 strategy, now under development, and the basis of the International Cooperation and Export national project. In this regard, medicine exports are becoming more and more relevant.
However, manufacturers find themselves in a difficult situation. While Russian medicines are in high demand in CIS countries, access to the highly competitive European market is possible only with government support and initiatives.
The round table discussion Export potential: new growth points, organised in partnership with GMP news magazine, will cover the following issues:
 - Opportunities to increase the export of pharmaceutical products
 - The most effective government support measures for manufacturers engaged in or planning to export
 - Priority areas of integrating into the global pharmaceutical market and do Russian companies have the opportunity to occupy their niche?
Representatives of regulators, leading industry experts, and pharmaceutical companies exporting medicines will discuss case studies and will try to address the most pressing questions.

Seminars - November, 19

19 November

11:00 - 13:00

Prezentation Zone B, Hall 8, Pavillion 2


Add to calendar 11/19/2019 11:00 11/19/2019 13:00 Seminar by Gluvex: Engineering problems. Yesterday, today, tomorrow Prezentation Zone B, Hall 8, Pavillion 2 Europe/Moscow

Seminars

Seminar by Gluvex: Engineering problems. Yesterday, today, tomorrow

Day 2

Discussion session: An effective view on technical support for medicines production

Place: Presentation Zone A, Hall 7, Pavillion 2
Participation: free, electronic ticket based
Language: Russian

Co-organised with: FPT 

20 November

11:00 - 13:30

Presentation Zone A, Hall 7, Pavillion 2


Add to calendar 11/20/2019 11:00 11/20/2019 13:30 An effective view on technical support for medicines production Due to the current state of the Russian economy and the decline in purchasing power of medicine users, manufacturers need to take action as soon as possible. Improving operational efficiency is becoming one of the most important tasks in the fight for profitability. Suppliers of equipment and services are also required to respond to this challenge and offer appropriate tools.
Participants of this session will discuss the issue of efficiency at different stages of a pharmaceutical enterprise’s life cycle. Issues of effective manufacturing engineering, including capital and operating costs, operational efficiency and ways to improve it will be discussed. Special attention will be paid to innovative solutions that improve efficiency at different stages of production.
Representatives of the manufacturers of technological equipment and medicines - BWT, Marchesini, IMA, FPT – are invited.
Presentation Zone A, Hall 7, Pavillion 2 Europe/Moscow

Discussion session

An effective view on technical support for medicines production

Due to the current state of the Russian economy and the decline in purchasing power of medicine users, manufacturers need to take action as soon as possible. Improving operational efficiency is becoming one of the most important tasks in the fight for profitability. Suppliers of equipment and services are also required to respond to this challenge and offer appropriate tools.
Participants of this session will discuss the issue of efficiency at different stages of a pharmaceutical enterprise’s life cycle. Issues of effective manufacturing engineering, including capital and operating costs, operational efficiency and ways to improve it will be discussed. Special attention will be paid to innovative solutions that improve efficiency at different stages of production.
Representatives of the manufacturers of technological equipment and medicines - BWT, Marchesini, IMA, FPT – are invited.

Round table discussion: API production: the economic aspect

Place: Presentation Zone A, Hall 7, Pavillion 2
Participation: free, electronic ticket based
Language: Russian

20 November

14:30 - 16:30

Presentation Zone A, Hall 7, Pavillion 2


Add to calendar 11/20/2019 14:30 11/20/2019 16:30 API production: the economic aspect Despite the decline in the supply of active pharmaceutical ingredients over recent years, financially, imports of APIs continue to grow. One of the key objectives of the Pharma 2030 programme is to provide the pharmaceutical industry with enough in terms of stock and quantity locally produced raw materials, primarily pharmaceutical substances. But there are factors that hinder the production growth of locally produced substances, the main one being the need for large investments, high material intensity and energy intensity of substance production. On the other hand, the resolution regulating public procurement of medicines, which came into force on 1 January 2019, introduced a new type of state support — a price preference of 25% of the minimum contract price. It will apply only to those companies that produce medicines in Russia and the EAEU countries on a full cycle, from the synthesis of the substance to packaging.
How can companies producing their own substances work according to the resolution and what economic benefits they can give? These and other issues will be discussed at the round table discussion API production: the economic aspect, on 20 November at Pharmtech & Ingredients.
Speakers will include representatives of regulatory bodies, leading industry experts, and representatives of API manufacturing companies.
Presentation Zone A, Hall 7, Pavillion 2 Europe/Moscow

Round table

API production: the economic aspect

Despite the decline in the supply of active pharmaceutical ingredients over recent years, financially, imports of APIs continue to grow. One of the key objectives of the Pharma 2030 programme is to provide the pharmaceutical industry with enough in terms of stock and quantity locally produced raw materials, primarily pharmaceutical substances. But there are factors that hinder the production growth of locally produced substances, the main one being the need for large investments, high material intensity and energy intensity of substance production. On the other hand, the resolution regulating public procurement of medicines, which came into force on 1 January 2019, introduced a new type of state support — a price preference of 25% of the minimum contract price. It will apply only to those companies that produce medicines in Russia and the EAEU countries on a full cycle, from the synthesis of the substance to packaging.
How can companies producing their own substances work according to the resolution and what economic benefits they can give? These and other issues will be discussed at the round table discussion API production: the economic aspect, on 20 November at Pharmtech & Ingredients.
Speakers will include representatives of regulatory bodies, leading industry experts, and representatives of API manufacturing companies.

Seminars - November, 20

20 November

11:00 - 12:00

Prezentation Zone B, Hall 8, Pavillion 2


Add to calendar 11/20/2019 11:00 11/20/2019 12:00 Seminar by Asahi Kasei Bioprocess Europe: PLANOVA Virus Removal Filters Prezentation Zone B, Hall 8, Pavillion 2 Europe/Moscow

Seminars

Seminar by Asahi Kasei Bioprocess Europe: PLANOVA Virus Removal Filters

20 November

12:10 - 14:10

Prezentation Zone B, Hall 8, Pavillion 2


Add to calendar 11/20/2019 12:10 11/20/2019 14:10 Seminar by GEA: Centrifuges and package units from GEA for human and veterinary vaccines, starter cultures production, human Blood Plasma Protein fractionation Prezentation Zone B, Hall 8, Pavillion 2 Europe/Moscow

Seminars

Seminar by GEA: Centrifuges and package units from GEA for human and veterinary vaccines, starter cultures production, human Blood Plasma Protein fractionation

Pharmtechprom forum - November, 20

Date: November, 20-21 
Place: Conference Hall C, Hall 7, Pavillion 2
Participation: free, electronic ticket based
Language: Russian

20 November

10:00 - 13:30

Session A – Raw materials and pharmaceutical ingredients. Moderator: Sergey Skvortsov, Elementoorganika (Russia), Managing Director

20 November

10:30 - 11:00

Conference Hall C, Hall 7, Pavillion 2


Add to calendar 11/20/2019 10:30 11/20/2019 11:00 Liquid and soft drugs formulation development with Super Refined excipients, eliminating instability and impurities issues Conference Hall C, Hall 7, Pavillion 2 Europe/Moscow

Session A – Raw materials and pharmaceutical ingredients

Liquid and soft drugs formulation development with Super Refined excipients, eliminating instability and impurities issues

Speakers

20 November

11:05 - 11:35

Conference Hall C, Hall 7, Pavillion 2


Add to calendar 11/20/2019 11:05 11/20/2019 11:35 Pharmaceutical ingredients: optimization of production from press to coater Conference Hall C, Hall 7, Pavillion 2 Europe/Moscow

Session A – Raw materials and pharmaceutical ingredients

Pharmaceutical ingredients: optimization of production from press to coater

Speakers

20 November

11:40 - 12:10

Conference Hall C, Hall 7, Pavillion 2


Add to calendar 11/20/2019 11:40 11/20/2019 12:10 Development of mucoadhesive drug delivery systems with Carbopols Conference Hall C, Hall 7, Pavillion 2 Europe/Moscow

Session A – Raw materials and pharmaceutical ingredients

Development of mucoadhesive drug delivery systems with Carbopols

Speakers

20 November

12:15 - 12:45

Conference Hall C, Hall 7, Pavillion 2


Add to calendar 11/20/2019 12:15 11/20/2019 12:45 Formulators’ tools to meet the requirements of contemporary drugs development Conference Hall C, Hall 7, Pavillion 2 Europe/Moscow

Session A – Raw materials and pharmaceutical ingredients

Formulators’ tools to meet the requirements of contemporary drugs development

Speakers

20 November

12:50 - 13:20

Conference Hall C, Hall 7, Pavillion 2


Add to calendar 11/20/2019 12:50 11/20/2019 13:20 Digital assistant for formulation development Conference Hall C, Hall 7, Pavillion 2 Europe/Moscow

Session A – Raw materials and pharmaceutical ingredients

Digital assistant for formulation development

Speakers

20 November

14:00 - 17:00

Session B – Technologies and equipment for pharmaceutical production. N. Pyatigorskaya, I.M. Sechenov First Moscow State Medical University, Head of Chair of Industrial Pharmacy, Pharm. D., Prof.

20 November

14:00 - 14:30

Conference Hall C, Hall 7, Pavillion 2


Add to calendar 11/20/2019 14:00 11/20/2019 14:30 Isolators for Chemical and Pharmaceuticals application: Process Equipment integration into HPAPI’s containment system Today the request of handling toxic compound in safe way is becoming more and more actual. From Charging reactors and preparation vessels to final packaging/filling operations the attention to operator safety and product protection has to be taken in consideration by using the right technology. Using rigid Isolators in most of the case is the only available solution to achieve both operator safety by process containment and product protection. The presentation is giving right indication in order to be able to select the proper containment system in function of the real necessity. Some case studies are also presented to show the state of the art and latest innovation in this field. Conference Hall C, Hall 7, Pavillion 2 Europe/Moscow

Session B – Technologies and equipment for pharmaceutical production

Isolators for Chemical and Pharmaceuticals application: Process Equipment integration into HPAPI’s containment system

Today the request of handling toxic compound in safe way is becoming more and more actual. From Charging reactors and preparation vessels to final packaging/filling operations the attention to operator safety and product protection has to be taken in consideration by using the right technology. Using rigid Isolators in most of the case is the only available solution to achieve both operator safety by process containment and product protection. The presentation is giving right indication in order to be able to select the proper containment system in function of the real necessity. Some case studies are also presented to show the state of the art and latest innovation in this field.

Speakers

20 November

14:35 - 15:05

Conference Hall C, Hall 7, Pavillion 2


Add to calendar 11/20/2019 14:35 11/20/2019 15:05 Gentle processing of ampoules and vials: One machine fits all Which general and upcoming trends are influencing sterile ampoule and vial filling and processing?
Which technical solutions are needed to meet these trends and to process liquid containers in an adequate and secure way?
Let´s have a deeper look on:
  • High speed processing
  • In-Line inspection
  • 100% In Process control
  • Flexibiltiy of filling systems
  • Minimizing of product loss
Conference Hall C, Hall 7, Pavillion 2 Europe/Moscow

Session B – Technologies and equipment for pharmaceutical production

Gentle processing of ampoules and vials: One machine fits all

Which general and upcoming trends are influencing sterile ampoule and vial filling and processing?
Which technical solutions are needed to meet these trends and to process liquid containers in an adequate and secure way?
Let´s have a deeper look on:

  • High speed processing
  • In-Line inspection
  • 100% In Process control
  • Flexibiltiy of filling systems
  • Minimizing of product loss

Speakers

20 November

15:10 - 15:40

Conference Hall C, Hall 7, Pavillion 2


Add to calendar 11/20/2019 15:10 11/20/2019 15:40 Handling from Powder and Liquid in the Pharmacy Mueller Systems is a leading manufacturer of stainless-steel containers, stainless steel drums and handling equipment, offering innovative solutions and the highest quality standards. Alongside perfecting stainless-steel drums, hoppers, silos and special stainless-steel containers together with stationary and mobile handling equipment for technical processing applications in various industrial areas. MCS cleaning systems are characterized by a definable cleaning and drying process.
 
Müller handling equipment figures:
– Stable, lightweight and durable
– Capacity: from 0,1 L to 2000 L
- Diameter: from 80 mm to 1200 mm
– Lidded drums and drums with bungs, cylindrical and conical
– Polished surfaces for optimum product discharge
– GMP pharmaceutical standard
– Modular design
 
The presentation will give the different types of containers for storage and transportation of liquids and powders offered by Müller, their characteristics and advantages of use.
Conference Hall C, Hall 7, Pavillion 2 Europe/Moscow

Session B – Technologies and equipment for pharmaceutical production

Handling from Powder and Liquid in the Pharmacy

Mueller Systems is a leading manufacturer of stainless-steel containers, stainless steel drums and handling equipment, offering innovative solutions and the highest quality standards. Alongside perfecting stainless-steel drums, hoppers, silos and special stainless-steel containers together with stationary and mobile handling equipment for technical processing applications in various industrial areas. MCS cleaning systems are characterized by a definable cleaning and drying process.
 
Müller handling equipment figures:
– Stable, lightweight and durable
– Capacity: from 0,1 L to 2000 L
- Diameter: from 80 mm to 1200 mm
– Lidded drums and drums with bungs, cylindrical and conical
– Polished surfaces for optimum product discharge
– GMP pharmaceutical standard
– Modular design
 
The presentation will give the different types of containers for storage and transportation of liquids and powders offered by Müller, their characteristics and advantages of use.

Speakers

20 November

15:45 - 16:15

Conference Hall C, Hall 7, Pavillion 2


Add to calendar 11/20/2019 15:45 11/20/2019 16:15 Suspension adaptation and process development of Multipotent Mesenchymal Stem Cells for cell therapy applications Human mesenchymal stem cells (hMSCs) have great potential as cellular therapeutics due to their ability to differentiate towards multiple lineages. Possible applications range from the treatment of Crohn’s disease to graft versus host disease and also target cardiovascular conditions among others.
To date, the generation of large numbers of hMSCs is typically achieved using two dimensional (2D) tissue culture vessels. However, this culturing approach requires a high level of operator manipulation and offers little in the way of culture control. A possible solution is the scale-up and large-scale production of hMSCs in three dimension (3D) culture on microcarriers utilizing stirred tank bioreactors. Here we demonstrate the utility of the ambr15 and ambr250 modular stirred tank bioreactor systems as valuable tools for hMSC process development and optimization paving the way for the large-scale production of clinically relevant numbers of hMSCs.
Conference Hall C, Hall 7, Pavillion 2 Europe/Moscow

Session B – Technologies and equipment for pharmaceutical production

Suspension adaptation and process development of Multipotent Mesenchymal Stem Cells for cell therapy applications

Human mesenchymal stem cells (hMSCs) have great potential as cellular therapeutics due to their ability to differentiate towards multiple lineages. Possible applications range from the treatment of Crohn’s disease to graft versus host disease and also target cardiovascular conditions among others.
To date, the generation of large numbers of hMSCs is typically achieved using two dimensional (2D) tissue culture vessels. However, this culturing approach requires a high level of operator manipulation and offers little in the way of culture control. A possible solution is the scale-up and large-scale production of hMSCs in three dimension (3D) culture on microcarriers utilizing stirred tank bioreactors. Here we demonstrate the utility of the ambr15 and ambr250 modular stirred tank bioreactor systems as valuable tools for hMSC process development and optimization paving the way for the large-scale production of clinically relevant numbers of hMSCs.

Speakers

Day 3

Seminars - November, 21

21 November

10:30 - 11:30

Prezentation Zone B, Hall 8, Pavillion 2


Add to calendar 11/21/2019 10:30 11/21/2019 11:30 Seminar by Alfa Lab: New criterias of protective clothing selection Prezentation Zone B, Hall 8, Pavillion 2 Europe/Moscow

Seminars

Seminar by Alfa Lab: New criterias of protective clothing selection

21 November

11:40 - 12:40

Prezentation Zone B, Hall 8, Pavillion 2


Add to calendar 11/21/2019 11:40 11/21/2019 12:40 Seminar by Alfa Lab: Advanced cleaning solutions with deconex® for the biotech production Prezentation Zone B, Hall 8, Pavillion 2 Europe/Moscow

Seminars

Seminar by Alfa Lab: Advanced cleaning solutions with deconex® for the biotech production

Pharmtechprom forum - November, 21

Date: November, 20-21 
Place: Conference Hall C, Hall 7, Pavillion 2
Participation: free, electronic ticket based
Language: Russian

21 November

10:00 - 13:30

Session C – Packaging equipment and materials. Moderator: Vladimir Stolypin, Erecton (Russia), Production Director, Ph.D.

21 November

14:00 - 17:00

Session D – Auxiliary processes in pharmaceutical production